Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
13.2M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
161K
-
Shares change
-
+55.1K
-
Total reported value, excl. options
-
$231K
-
Value change
-
+$79.3K
-
Number of buys
-
6
-
Price
-
$1.44
Significant Holders of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) as of Q4 2023
10 filings reported holding SILO - Silo Pharma, Inc. - Common stock, par value $0.0001 per share as of Q4 2023.
Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 161K shares
of 13.2M outstanding shares and own 1.21% of the company stock.
Largest 10 shareholders include Financial Advocates Investment Management (62.8K shares), UBS Group AG (32.8K shares), VANGUARD GROUP INC (16.3K shares), GEODE CAPITAL MANAGEMENT, LLC (16.2K shares), TWO SIGMA SECURITIES, LLC (12.8K shares), STATE STREET CORP (12.5K shares), Tower Research Capital LLC (TRC) (7.01K shares), Westside Investment Management, Inc. (94 shares), FWL INVESTMENT MANAGEMENT, LLC (80 shares), and WELLS FARGO & COMPANY/MN (20 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.